OSRHW
HealthcareBellevue Life Sciences Acquisition Corp - Warrants (09/02/2028)
$0.06+0.01 (+19.80%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving OSRHW Today?
No stock-specific AI insight has been generated for OSRHW yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding—
OSRHW News
20 articles- Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price TargetYahoo Finance·May 5, 2026
- OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026Yahoo Finance·Apr 30, 2026
- OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM EuropeYahoo Finance·Apr 29, 2026
- OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible NoteYahoo Finance·Apr 9, 2026
- Presenting on Emerging Growth Conference 91 Day 1 on April 1; Register to live streamYahoo Finance·Mar 31, 2026
- OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026Yahoo Finance·Mar 30, 2026
- Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price TargetYahoo Finance·Mar 27, 2026
- OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent LevelYahoo Finance·Mar 23, 2026
- Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter TrialsYahoo Finance·Mar 19, 2026
- Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial OpportunitiesYahoo Finance·Mar 19, 2026
- OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology ExpansionYahoo Finance·Nov 14, 2025
- OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot StudyYahoo Finance·Nov 6, 2025
- Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price TargetYahoo Finance·Oct 20, 2025
- OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes CareYahoo Finance·Oct 14, 2025
- OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading ActivityYahoo Finance·Sep 9, 2025
- BC-Most Active StocksYahoo Finance·Aug 25, 2025
- OSR Holdings Second Quarter 2025 Earnings: EPS: US$0.02 (vs US$1.83 loss in 2Q 2024)Yahoo Finance·Aug 20, 2025
- OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025Yahoo Finance·Aug 1, 2025
- OSR Holdings Provides Transparency Update on Equity Financing InstrumentsYahoo Finance·Jul 31, 2025
- OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange StructureYahoo Finance·Jul 30, 2025
All 20 articles loaded
Price Data
Open$0.06
Previous Close$0.05
Day High$0.06
Day Low$0.05
52 Week High—
52 Week Low—
Fundamentals
Market Cap—
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding—
About Bellevue Life Sciences Acquisition Corp - Warrants (09/02/2028)
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
HealthcareSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Details
Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SICSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CIK—
Composite FIGI—
Share Class FIGI—